CAS 1235-82-1
:Chlorhydrate de bipéridène
- 1-(Bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride
- 1-(Bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride (1:1)
- 1-Bicyclo[2.2.1]Hept-5-En-2-Yl-1-Phenyl-3-Piperidin-1-Ylpropan-1-Ol Hydrochloride
- 1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-ylpropan-1-olhydrochlorid
- 1-Bicycloheptenyl-1-phenyl-3-piperidinopropanol Hydrochloride
- 1-Piperidinepropanol, .alpha.-bicyclo[2.2.1]hept-5-en-2-yl-.alpha.-phenyl-, hydrochloride
- 1-Piperidinepropanol, alpha-bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-, hydrochloride (1:1)
- 1-Piperidinepropanol, α-5-norbornen-2-yl-α-phenyl-, hydrochloride
- 1-Piperidinepropanol, α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-, hydrochloride
- 1-Piperidinepropanol, α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-, hydrochloride (1:1)
- 1235-82-1
- 214-976-2
- Akineton hydrochloride
- Akinophyl
- Biperidene hydrochloride
- NSC 170950
- NSC 84989
- Tasmolin
- Voir plus de synonymes
BIPERIDEN HYDROCHLORIDE CRS
CAS :BIPERIDEN HYDROCHLORIDE CRSFormule :C21H30ClNOCouleur et forme :PowderMasse moléculaire :347.922BIPERIDEN HYDROCHLORIDE RS
CAS :BIPERIDEN HYDROCHLORIDE RSFormule :C21H30ClNOCouleur et forme :PowderMasse moléculaire :347.9221-(Bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride
CAS :1-(Bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochlorideDegré de pureté :98%Masse moléculaire :347.93g/molBiperiden Hydrochloride
CAS :Biperiden HCl is an anti-Parkinson's drug, blocks M1 receptors, manages all Parkinson's types, and is FDA-approved. Non-toxic at 0.11 mg/kg to rats' cognition.Formule :C21H30ClNODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :347.92Biperiden HCl - Bio-X ™
CAS :Produit contrôléBiperiden is a muscarinic antagonist drug that is used in the treatment of Parkinson's disease and other conditions. Biperiden binds to the dopamine D2 receptor, which inhibits the release of dopamine from presynaptic neurons. It also possesses nicotinolytic activity.Formule :C21H29NO·HClDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :347.92 g/molBiperiden hydrochloride
CAS :Produit contrôléBiperiden hydrochloride is an anticholinergic medication, which is a synthetic derivative. It exerts its effects primarily through the central nervous system by blocking acetylcholine receptors. This blockade reduces the activity of acetylcholine, a neurotransmitter, which plays a role in muscle contractions and various neural functions. By antagonizing the muscarinic receptors, Biperiden hydrochloride helps in modulating the balance between neurotransmitters in the brain.
Formule :C21H29NO•HClDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :347.92 g/molBiperiden hydrochloride
CAS :Produit contrôléBiperiden hydrochloride is a potent, centrally acting anticholinergic agent that has been used to treat Parkinson's disease and other extrapyramidal disorders. Biperiden hydrochloride works by blocking the transmission of nerve impulses in the brain by inhibiting acetylcholine at the synapse. It also inhibits dopamine release and blocks postsynaptic dopamine receptors. Biperiden hydrochloride is used in vitro to study the effects of drugs on human serum and urine samples, as well as for diagnostic purposes in vivo. In vitro assays are also conducted to study the effect of drugs on locomotor activity and symptoms in animals. Biperiden hydrochloride can be combined with mianserin hydrochloride or fluorescein angiography to study the function of dopaminergic systems in vivo.Formule :C21H30ClNODegré de pureté :Min. 94 Area-%Masse moléculaire :347.93 g/molBiperiden Hydrochloride-d5 (Mixture of Diastereomers)
CAS :Produit contrôléApplications Biperiden Hydrochloride-d5 is the isotope labelled analog of Biperiden Hydrochloride (B397825); an antiparkinsonian and non-selective muscarinic receptor antagonist. Biperiden is used for the adjunctive treatment of all forms of Parkinson′s Disease (postencephalitic, idiopathic, and arteriosclerotic) and is also commonly used to improve parkinsonian signs and symptoms related to antipsychotic drug therapy.
References Patela, Y., et al.: Talanta, 47, 625 (1998); Bebawy, L., et al: J. Pharm. Biomed. Anal., 20, 663 (1999); Dinc, E., et al.: J. Pharm. Biomed. Anal., 28, 591 (2002)Formule :C21D5H24NO·HClCouleur et forme :Off-WhiteMasse moléculaire :352.953











